Search Articles — Sudonull

https://sudonull.com/ai-music-spotify-and-universal-music-introduced-a-paid-model

Spotify and UMG legalized AI covers and remixes for premium subscribers. Who will win and who will lose from the new paid model? Detailed analysis.

https://sudonull.com/telegram-bots-for-tasks-comparison-of-skeddybot-remindmegabot-smartscheduler-menoapp

Detailed analysis of 4 Telegram bots for task management. Find out which bot is suitable for voice input, flexible reminders or AI planning.

https://sudonull.com/moderna-s-personalized-mrna-vaccine-against-pancreatic-cancer-78-effect

Moderna released a personalized mRNA vaccine against pancreatic cancer: remission in 78% of patients over 18 months. FDA accelerated approval. Analysis of efficacy and risks.

https://sudonull.com/marusya-and-salut-vulnerabilities-bypassing-filters

Analysis of Technical Loopholes in Voice Assistants Marusya and Salut. Prompt injection via Choices, Memory, and Reminders. Protection Recommendations for LLM Developers.

https://ymaho.com/car-t-therapy-for-lupus-100-remission-in-a-small-cohort

German rheumatologists achieved 100% remission in lupus with CAR-T. Four-year data, immune reset mechanism, and forecasts. Read.

https://ymaho.com/dual-action-car-t-100-remission-in-myeloma-at-isct-2026

ISCT 2026 data analysis: CAR-T therapy TPST-2003 showed complete response in all naive patients. Learn why this is a breakthrough, not an illusion, and what risks are hidden.

https://ymaho.com/car-t-therapy-hiv-years-of-remission-after-infusion

DUET-2 data: CAR-T cells keep HIV in remission for over 2 years without ART. Functional cure already a reality? Learn about the breakthrough in HIV treatment.

https://ymaho.com/adc-drug-decnupaz-treatment-of-ultra-rare-blood-cancer-bpdcn

FDA approved pivekimab sunirin (Decnupaz) for BPDCN with complete remission of 69.7%. Analysis of efficacy, risks, price, and prospects in AML. Read more.

https://ymaho.com/moderna-vaccine-shrank-tumors-in-83-of-melanoma-patients

mRNA drug mRNA-4359 with Keytruda showed 83% response and 17% complete remissions. Even PD-L1-negative tumors shrank. Learn how a ready-made vaccine teaches the immune system to attack cancer without personalization.

https://lrivo.com/gibbs-white-hat-trick-haunts-spurs-boosts-forest-survival

Morgan Gibbs-White's hat-trick for Nottingham Forest pushes them toward safety and reminds Tottenham of a failed transfer. Analysis of the pivotal saga and match impact.

https://ymaho.com/targeted-therapy-for-ultra-rare-blood-cancer-fda-approves-pivekimab-sunirin

FDA has registered the first targeted therapy for BPDCN — pivekimab sunirin. Remission rate 69.7%, but there are risks. Detailed analysis of the drug and consequences.

https://ymaho.com/breakthrough-in-depression-treatment-neurosteroids-psilocybin-and-caplyta

FDA approved zuranolone, psilocybin passed phase III, and Caplyta doubles the chance of remission. Learn how moving away from the serotonin theory and new NMDA antagonists are changing psychiatry in 2026.

https://ymaho.com/mobile-money-transfers-how-phones-replace-banks-abroad-explained

Learn how Telcoin uses mobile networks and blockchain to make cross-border payments faster and cheaper. No bank account needed — just your phone.

https://ymaho.com/telcoin-guide-phone-based-global-payments-explained

Learn how Telcoin uses mobile networks to simplify cross-border payments. Understand its token system and real-world potential for the unbanked. Read now.